Whole genome: next-generation sequencing as a virus safety test for biotechnological products.

PDA J Pharm Sci Technol

PathoQuest, Bâtiment François Jacob, Paris, France; and Institut Pasteur, Laboratory of Pathogen Discovery, Department of Virology, Paris, France

Published: January 2018

The availability of next-generation sequencing techniques is about to strongly modify the strategies of control of the viral safety of biologicals products. It is now possible to use the tools of metagenomics, which is the study of the microbial genetic sequences recovered directly from a given sample. In this setting, the sequence of all the nucleic acids species of the sample are determined and compared with those in databases. We describe the pipeline we are currently using and show comparison of its analytical sensitivity with that of polymerase chain reaction together with results of time course experiments in infected cells. We propose to test cell supernatants for viral genomes associated to capsids and testing cells for viral RNA transcripts as the hallmark for virus replication, and we suggest rules of interpretation of the results. We also discuss the applicability of next-generation sequencing for the control of raw materials.

Download full-text PDF

Source
http://dx.doi.org/10.5731/pdajpst.2014.01015DOI Listing

Publication Analysis

Top Keywords

next-generation sequencing
12
genome next-generation
4
sequencing virus
4
virus safety
4
safety test
4
test biotechnological
4
biotechnological products
4
products availability
4
availability next-generation
4
sequencing techniques
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!